Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation

American Journal of Transplantation

Volumn 7, Issue 2, 2007, Pages 416-422

  Bayes B ^a   Granada, M L ^a   Pastor, M C ^a   Lauzurica, R ^a   Salinas, I ^a   Sanmarti A ^a   Espinal, A ^a   Serra, A ^a   Navarro, M ^a   Bonal, J ^a   Romero, R ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Adiponectin; CRP; IL 6; Inflammation; Kidney transplantation; New onset diabetes mellitus after transplantation (NODAT); Obesity; PAPP A; TNF

Indexed keywords

ADIPONECTIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCINEURIN INHIBITOR; CALCIUM ANTAGONIST; CORTICOSTEROID; CYCLOSPORIN A; DIURETIC AGENT; GLUCOSE; INSULIN; INTERLEUKIN 6; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MARKER; DRUG DOSE REDUCTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN BLOOD LEVEL; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PREDICTIVE VALIDITY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADIPONECTIN; ADULT; BODY MASS INDEX; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33846224679     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01646.x     Document Type: Article

References (25)

1. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-185.
2. Heisel O, Heisel R, Balshaw R, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis. Am J Transplant 2004; 4: 583-595.
3. Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-47.
4. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111-1119.
5. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-334.
6. Spranger J, Kroke A, Möhlig M et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361 226-228.
7. Bayés B, Lauzurica R, Granada ML et al. Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation. Transplantation. 2004; 78: 26-30.
8. Lawrence JB, Oxvig C, Overgaard MT et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 1999; 96: 3149-3153.
9. Bayes-Genis A, Conover C, Overgaard M et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001; 345: 1022-1029.
10. American Diabetes association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27: S5-S10.
11. Davidson J, Wilkinson A, Dantal J et al. New-onset diabetes after transplantation: 2003 international consensus guidelines. Proceedings of an international expert panel meeting. Transplantation 2003; 75: SS3-S24.
12. Baltar J, Ortega T, Ortega F et al. Posttransplantation diabetes mellitus: Prevalence and risk factors. Transplant Proc 2005; 37: 3817-3818.
13. Wajchenberg BL. Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697-738.
14. Serra A, Granada ML, Romero R et al. The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clin Nutr 2006; 25: 400-408.
15. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 1994; 94: 1543-1549.
16. Stephens JM, Pekala PH. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem 1991; 266: 21839-21845.
17. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
18. Bluher M, Kratzsch J, Paschke R. Plasma levels of tumor necrosis factor-alpha, angiotensin-II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance. Diabetes Care 2001; 24: 328-334.
19. Fernández-Real JM, Vayreda M, Richart C et al. Circulating interleukin 6 levels, blood pressure and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001; 86: 1154-1159.
20. Vozarova B, Weyer C, Hanson K, Tatarani PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001; 9: 414-417.
21. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749.
22. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935.
23. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 1999; 341: 461-467.
24. Bayés-Genís A, Conover CA, Schwartz RS. The Insulin-like growth factor axis. A review of atherosclerosis and restenosis. Circ Res 2000; 86: 125-130.
25. Lauzurica R, Pastor C, Bayés B, Hernandez JM, Romero R. Pretransplant pregnancy-associated plasma protein-a as a predictor of chronic allograft nephropathy and post transplant cardiovascular events. Transplantation 2005; 80: 1441-1446.